Campbell Soup Company

---

ticker: CPB source: coverage-next-full step: 01 coverage_date: 2026-05-28

CPB — Step 01: Business Model & Overview

Key Findings

The Campbell's Company is a brand-owner + manufacturer + distributor of US center-store packaged food, with two reportable segments and 16 leadership brands [S1]. The business model is mature, generates predictable cash flow ($1.1B+ OCF annually [S2]), and depends on three economic engines: (1) brand pricing power in mature categories (soup ~58% share, premium pasta sauce via Rao's) [S3]; (2) scale economics in procurement and manufacturing (~30 plants, 14,500 employees) [S6]; and (3) shelf and DSD distribution advantage at major retailers (Walmart ~22% of sales) [S6]. Net positive for stability, net mixed for growth — most leadership brands are in flat-to-declining categories, with growth concentrated in Rao's and a small set of premium SKUs.

Implications for Thesis and Valuation

• Predictable cash-generative business suitable for a DCF + dividend yield lens. Steady-state FCF $700–900M base case.
• Limited organic growth (low-single-digit at best) means valuation expansion has to come from re-rating, not earnings explosion.
• Walmart concentration is the single most important channel risk — any shift in shelf allocation or private-label expansion could pressure 10–20% of revenue.
• Brand portfolio is bimodal — a few iconic brands ($1B+) with durable moats, and a long tail of legacy SKUs (V8, Pace, SpaghettiOs, Lance) in slow decline.

Objective

Map CPB's revenue model, segment structure, brand portfolio, customer/channel mix, and value-chain position to set the analytical frame for Steps 02–18.

Narrative Analysis

What CPB Sells

Two segments, restated as of FY2026 to move Latin America retail snacking from Snacks to Meals & Beverages [S5]:

Meals & Beverages (FY25: $6.05B, 59% of revenue):

• Soup: Campbell's condensed + ready-to-serve, Chunky, Pacific Foods broth — foundational category, ~58% US share for CPB [S3]
• Pasta sauce: Prego (mid-tier) + Rao's (premium, acquired March 2024 via Sovos) [S6]
• Other meals: Pace Mexican sauces, SpaghettiOs, Swanson canned poultry [S6]
• Beverages: V8 juices, Campbell's tomato juice — long-tail category in slow decline [S3]
• Frozen: Rao's frozen entrées + frozen pizza, Michael Angelo's frozen Italian (Sovos-acquired) [S6]

Snacks (FY25: $4.20B, 41% of revenue):

• Pepperidge Farm: cookies (Milano, Goldfish), crackers, fresh bakery, frozen pastries [S6]
• Goldfish crackers: largest standalone brand in Snacks [S6]
• Snyder's of Hanover pretzels (acquired 2018 via Snyder's-Lance) [S6]
• Lance sandwich crackers, Cape Cod potato chips, Kettle Brand potato chips [S6]
• Late July organic snacks, Snack Factory pretzel crisps [S6]
• Pop Secret popcorn divested Aug 2024 [S2]

Leadership Brand Concentration

Brand	Approx FY25 revenue	Category	Trend
Campbell's (soup)	~$2.5B+	Soup	Slow decline -2 to -4%/yr secularly [S3]
Goldfish	~$1.3B+	Cracker snacks	Flattening after multi-year growth [S3]
Pepperidge Farm	~$1.5B+	Cookies + bakery	Mixed; Milano resilient [S3]
Rao's	~$900M (approaching $1B)	Premium pasta sauce + frozen	Growing high-single to low-double-digit [S2][S6]
Snyder's of Hanover	~$700M	Pretzels	-5% to -10% YoY in tracked channels [S2]
Lance	~$400M	Sandwich crackers	Declining [S2]
Cape Cod + Kettle Brand	~$500M combined	Premium chips	Mixed [S3]
Swanson + Pacific Foods + Chunky + Prego + V8 + Pace + Late July + Snack Factory	~$2.4B aggregate	Various	Mostly flat/slow decline [S3]

Three $1B+ brands (Campbell's, Goldfish, Pepperidge Farm) + Rao's approaching $1B = ~$6B+ revenue concentration in 4 brands (~58% of total).

Value-Chain Position

CPB occupies the brand owner + manufacturer + DSD/warehouse distributor layer of the food value chain:

Layer	Role	CPB ownership
Raw materials (wheat, tomato, dairy, aluminum)	Sourced from commodity markets / contract farmers	No (supply risk)
Co-packing / contract manufacturing	Limited (~10–15% of volume)	Partial
Owned manufacturing	~30 plants across US + Italy (Rao's pasta sauce)	Yes (primary)
Brand IP + product development	Owned; A&P spend 9–10% of sales	Yes
Direct-store-delivery (DSD)	Pepperidge Farm + Snyder's-Lance use DSD; rest is warehouse	Yes for snacks DSD
Retail shelf	Negotiated with WMT, COST, KR, AMZN, others	Sells in
Consumer	Households (no D2C)	Indirect

The DSD network (inherited from Snyder's-Lance 2018) is a real moat for Snacks — it locks in shelf presence + freshness control + retail relationships, hard to replicate.

Channel Mix

Channel	Approx %	Notes
Walmart + Sam's Club	~22%	Largest single customer [S6]
Costco	~8–10% (est.)	Premium tier + Rao's strong here
Kroger	~7–10% (est.)	Mainstream supermarket
Amazon (digital)	~3–5% (est.)	Growing
Other supermarket / club / mass	~40%	Albertsons, Publix, Target, etc.
Foodservice (Pacific, Lance, broth)	~10–12%	Long-tail B2B
International (Canada + Latin Am)	~5–8%	Small but growing in Latin Am

Why CPB Renamed in Nov 2024

The "Campbell Soup Company" name underweighted the now-41%-of-revenue Snacks business plus Rao's premium pasta sauce. "The Campbell's Company" positions the portfolio as a brand house rather than a soup specialist [S6]. Symbolically signals that the snacks acquisition strategy (Snyder's-Lance 2018, Sovos 2024) is the go-forward identity.

Evidence and Sources

See Source Index. Key facts cross-confirmed across XBRL summary, Q4 FY25 earnings release, 10-K business section, and industry coverage.

Assumption Register Updates

• (No new assumptions this step; A4 Walmart 22% concentration already entered in Step 00)

Tables and Calculations

See Leadership Brand Concentration table above.

Open Questions and Data Gaps

1. Exact Rao's quarterly revenue not disclosed — only "approaching $1B" framing
2. DSD network economics (truck count, route density, route productivity vs Frito-Lay) not in public disclosures
3. Walmart relationship terms (joint business plans, slotting fees) not public
4. Foodservice subsegment growth and margins not separately disclosed

Next-Step Dependencies

• Step 02 (Industry) inherits brand → category mapping
• Step 03 (Revenue Architecture) decomposes the $10.3B into growth drivers
• Step 07 (Capital Allocation) uses Snyder's-Lance + Sovos acquisitions for the M&A scorecard
• Step 10 (Moat) uses brand + DSD + scale framing here

Source Index

Tag	Document	Path	Notes
[S1]	SEC XBRL companyfacts API + FY25 10-K	CPB_financials/xbrl/xbrl_summary.md	Segment revenue + structure
[S2]	Q4 FY25 press release (Ex 99.1, 8-K filed 2025-09-03)	CPB_financials/sec_filings/10K_FY2025_summary.md	Segment results + brand commentary
[S3]	Industry overview research	CPB_financials/industry/market_overview.md	Category share + dynamics
[S4]	Q2 FY26 press release + consensus	CPB_financials/other/consensus.md	Updated guidance
[S5]	Segment recast 8-K (filed 2025-12-09)	sec_filings/filing_inventory.md	FY26 segment realignment
[S6]	FY25 10-K summary	CPB_financials/sec_filings/10K_FY2025_summary.md	Brand list + Walmart concentration + M&A history

---

ticker: CPB source: coverage-next-full step: 04 coverage_date: 2026-05-28

CPB — Step 04: Financial Quality & Adversarial Sweep

Key Findings

CPB's financial quality is mediocre but not impaired. The gap between GAAP EPS ($2.01 FY25) and adjusted EPS ($2.97 FY25) is wide — $0.96/share of add-backs, of which the largest items are non-cash impairment ($0.44), cost-savings/optimization opex ($0.32), and divestiture charges ($0.11) [S1]. These are accounting-noisy but mostly legitimate (PPA-driven non-cash + integration costs that will eventually anniversary). Cash flow quality is acceptable: OCF $1.13B converts to FCF $705M (5% of revenue), with $145M of PEAK savings already in the run-rate [S1][S2]. The adversarial sweep finds no smoking-gun short report, no SEC investigation, and no major accounting restatement — but does surface (1) PFAS litigation overhang in soup/broth cans, (2) labeling lawsuits (typical CPG nuisance), (3) historical FY24 cybersecurity incident referenced in non-GAAP reconciliation [S1], and (4) the question of whether Sovos/Rao's goodwill ($1.1B+ allocated) is at risk of impairment if premium frozen growth disappoints.

Implications for Thesis and Valuation

• Use adjusted EPS for valuation lens but recognize $0.20–$0.30 of adjustments will be recurring through FY27 (integration + PEAK opex)
• Watch goodwill ($4.99B) + other intangibles ($4.34B) = $9.3B — 61% of total assets. Even a 10% Sovos goodwill impairment would be a $300M+ non-cash hit
• No quality red flags requiring investigation discount — straightforward CPG accounting
• FCF coverage of dividend tight (1.5x) — financial flexibility limited

Objective

Score financial-statement quality, reconcile GAAP-to-adjusted gap, conduct the adversarial research sweep, and flag any quality issues that should adjust valuation.

Narrative Analysis

Adjusted-to-GAAP Reconciliation (FY25)

Item	$/share	$M (approx)	Quality assessment
GAAP diluted EPS	$2.01	$602 NI	Reported
Cost savings + optimization opex	$0.32	$96	Recurring during integration; will anniversary by FY28
Commodity MTM (gains)/losses	-$0.03	-$9	Non-cash; appropriate to exclude
Accelerated amortization	$0.05	$15	Non-cash; PPA-driven
Divestiture charges	$0.11	$33	Non-recurring; noosa + Pop Secret
Litigation expenses	$0.02	$6	Nuisance; recurring at low level
Impairment charges	$0.44	$132	Non-cash; PPA-driven (Sovos)
Pension actuarial losses	$0.06	$18	Non-cash; rate-driven
Adjusted EPS	$2.97	$892	Used for valuation

[S1]

Quality of Earnings — Cash Conversion

FY	Net Income (GAAP)	OCF	OCF / NI	FCF	FCF / Adj NI
FY22	757	1,181	156%	939	86%
FY23	858	1,143	133%	773	65% (capex spike)
FY24	567	1,185	209%	668	65% (Sovos drag)
FY25	602	1,131	188%	705	79%

Source: SEC XBRL [S2]. OCF/NI >100% reflects D&A + non-cash add-backs (typical for mature CPG with heavy intangibles).

Read: Cash conversion is solid; the GAAP NI is depressed by non-cash items (D&A on PPA intangibles, impairments). FCF / Adj NI of ~80% is normal for a CPG with 4–5% capex intensity.

Working Capital Quality

• DSO: ~30 days (typical CPG; mostly large retail customer credit)
• DIO: ~50 days (typical; some seasonality in soup ahead of winter)
• DPO: ~45 days
• Cash conversion cycle: ~35 days — stable, no degradation

(Not extracted line-by-line in this run; derived from quarterly balance-sheet ratios.)

Goodwill + Intangibles Concentration

Item	Q2 FY26	% of Assets
Total assets	$15,348M	100%
Goodwill	$4,992M	32.5%
Other intangibles (mostly indefinite-lived trade names)	$4,335M	28.2%
Combined intangibles	$9,327M	60.7%

[S2]

Concentration risk: A 10% impairment on goodwill or indefinite intangibles would be a $500M+ non-cash hit ($1.67/share) — material on a $20 stock. Most likely impairment candidates: Sovos goodwill (~$1.1B PPA bump from $2.7B deal less ~$1.7B intangibles) and Snyder's-Lance legacy goodwill if Snacks margins continue to compress.

Adversarial Research Sweep

Short Reports / Activist Targets

• No active short report identified via web search (Citron, Hindenburg, Spruce Point, etc.) [S3]
• Short interest: moderate (~5–7% of float typical for a distressed staples name; not a heavily shorted name)
• No active activist campaign. Third Point made noise in 2018; nothing material since.

SEC Investigations / Enforcement

• No active SEC investigation identified.
• Historical: standard FCPA monitoring at Sovos pre-acquisition; integrated into CPB compliance.

Litigation

• PFAS lawsuits — packaged-food companies including CPB face class actions related to packaging materials (soup cans, Rao's jars). Status: early-stage, no material accrual disclosed.
• Labeling lawsuits — periodic (vegetable juice "fresh" labeling, organic claims). Standard CPG nuisance — captured in $6M FY25 "litigation expenses" add-back.
• Cybersecurity incident — FY24 cyber incident referenced in non-GAAP reconciliation; appears resolved with no material data loss or ransom.

Accounting Red Flags

• No restatements in last 10 years (per SEC EDGAR review).
• No 10-K/A amendments of substance.
• Internal control material weaknesses: none disclosed in FY25 10-K.
• Auditor: PricewaterhouseCoopers LLP (long-tenured); no auditor changes recently.

Segment-Reporting Restatement (FY26)

Beginning FY26, the Latin America snacking/M&B retail business moved from Snacks to Meals & Beverages segment [S4]. This is a clean restatement (recast filed Dec 9, 2025 8-K with full historical data) — not a red flag, but worth noting because it slightly improves the optical Snacks margin in restated history (removed some weaker LatAm volume).

Auditor + Audit Committee

• Auditor: PwC
• Audit committee chair: long-tenured independent director (per proxy)
• No going-concern flag; no critical audit matters of unusual concern

Compensation-Driven Earnings Manipulation Risk

• PSU vesting tied to 3-year adj EPS + relative TSR — could incentivize aggressive adjustments
• BUT historical add-backs have been consistent + auditor-reviewed
• The $0.44 FY25 impairment add-back is the largest single item — it relates to a noosa-related goodwill write-down (divested), not strategic FY25 EPS engineering

Evidence and Sources

Negative Quality Signals

Signal	Severity	Status
Wide GAAP-to-adj EPS gap ($0.96/share)	Medium	Largely non-cash + integration; will narrow
High intangibles concentration ($9.3B)	Medium	Watchpoint for future impairment
FCF coverage of dividend (1.5x)	Medium	Tight; not impaired
Long-term inflation in net debt ($4B → $7B)	High	Sovos-driven; deleveraging path slow
Repeated cost-savings opex add-backs	Low-Medium	Recurring but legitimate

Positive Quality Signals

Signal	Comment
OCF / NI >150% multi-year	Strong cash conversion
No SEC investigations, restatements, or material weaknesses	Clean control environment
Long-tenured Big 4 auditor (PwC)	Audit continuity
40+ year dividend record (uninterrupted)	Capital return discipline
Family-trust ownership (Dorrance) limits short-term earnings games	Long-term orientation

Assumption Register Updates

• No new assumptions; quality assessment supports existing A14 WACC at 6.5–7%

Tables and Calculations

See Adjusted-to-GAAP Reconciliation + Goodwill/Intangibles Concentration tables.

Open Questions and Data Gaps

1. PFAS litigation accrual amount (if any) not disclosed
2. Goodwill impairment testing assumptions for Sovos / Snyder's-Lance not in MD&A detail
3. Cybersecurity incident cost not separately quantified (rolled into reconciliation)
4. Tax position on Italian Rao's manufacturing (transfer pricing) not addressed

Next-Step Dependencies

• Step 06 (Balance Sheet) deepens debt + share count detail
• Step 11 (External Risk) revisits PFAS + tariff + commodity
• /complete-coverage Step 14 (Valuation) uses adjusted EPS framework set here

Source Index

Tag	Document	Path	Notes
[S1]	Q4 FY25 release adj reconciliation	sec_filings/10K_FY2025_summary.md + other/consensus.md	EPS bridge detail
[S2]	SEC XBRL	xbrl/xbrl_summary.md	OCF + NI + Balance Sheet history
[S3]	Web search (no short report identified)	(negative result)	Adversarial sweep
[S4]	Segment recast 8-K (Dec 9, 2025)	sec_filings/filing_inventory.md	FY26 segment restatement

---

ticker: CPB source: coverage-next-full step: 12 coverage_date: 2026-05-28

CPB — Step 12: Bull vs Bear (Analyst Debate)

Key Findings

The investable debate on CPB resolves into a single question: Is FY26 the trough on adjusted EPS, and is the dividend secure on the path forward? The bull case argues yes — PEAK savings ($375M cumulative by FY28) layer in, Sovos integration completes, Snacks volume bottoms by FY27, tariff mitigation matures to 80%+ — driving a ~25% upside to fair value of $26–28 plus a 7%+ dividend yield (~32% total return over 18–24 months). The bear case argues no — GLP-1 secular Snacks impairment + tariff persistence + slow deleveraging combine to keep ROIC at WACC, dividend coverage thins below 1.2x, and a dividend cut becomes inevitable by FY27 — driving downside to $15–17 (-25%) on multiple compression. The market currently prices CPB at ~9.5x forward P/E on $2.20 mid EPS = ~$21 — implying the market believes either the trough is close but the recovery is muted, or that the dividend will be cut. The variant view (Step 16) tests whether the dividend safety is mispriced.

Implications for Thesis and Valuation

• Expected value framing requires both Bull/Bear probabilities — base case (~$22) is closer to current price than either tail
• Asymmetry is modest: ~+25% upside vs ~-25% downside in 18-month view
• Dividend yield is the contrarian's safety net — receive 7.5% yield while waiting for thesis to resolve
• Q3 FY26 print (June 2026) is the highest-information event — confirms or denies the trough thesis

Objective

Construct the analyst-debate framework: bull view, bear view, what they agree on, what would change each side's mind. Without transcripts, the debate is inferred from consensus reports, press releases, and recent news flow. This section feeds /complete-coverage Step 15 (Scenarios) and the public /stocks/[ticker] Bull/Bear panel.

Narrative Analysis

Transcript-Free Disclaimer

This section follows the coverage-next-full path: no transcripts loaded. The debate is reconstructed from:

• Consensus reports + analyst PT changes (from other/consensus.md)
• Q2 FY26 press release language (March 11, 2026)
• Investor Day Sept 2024 framework
• Industry/buy-side commentary in news flow

Transcript review would have added: specific Q&A push-back on dividend safety, analyst question intensity on tariff mitigation, Beekhuizen's verbal hedging level, and Sovos integration commentary nuance.

What Both Sides Agree On

Agreement	Source
FY26 adj EPS will be $2.15–$2.25 (mid $2.20)	Company guidance Mar 2026 [S3]
Sovos / Rao's is delivering on growth ("approaching $1B" annualized)	Q4 FY25 release [S1]
Tariffs are a material 230 bps gross margin headwind	Q2 FY26 release [S3]
Snacks volume is in -3% to -5% decline	Quarterly results [S1][S3]
PEAK savings of $375M by FY28 is realistic	Investor Day [S4]
Net debt / EBITDA at ~4.3x is elevated	XBRL [S2]
CEO Beekhuizen is competent if untested	Filings [S5]
Dorrance family ownership is passive	Form 4 [S6]
Industry structure (retailer power, private label) is worsening	Industry research [S7]

Where They Disagree

Topic	Bull View	Bear View
Is FY26 the trough?	Yes — PEAK + Sovos + tariff mitigation layer in FY27	No — GLP-1 + tariff persistence + Snacks decay = FY27 weaker
Is dividend safe?	Yes — 1.5x FY25 coverage, room to absorb 1.2x	No — bear case 1.0x coverage forces cut by FY27
Snacks recovery?	Stabilizing in FY27; Rao's offsetting	Secular decline; -5%/yr GLP-1 impact
Tariff mitigation?	60%→80% by FY27	Tariffs persist; pricing fatigue limits pass-through
Multiple re-rating?	Yes — 9.5x → 11–12x on FY27 EPS recovery	No — at-WACC ROIC + GLP-1 = permanent de-rating
Sovos return?	Rao's "premium meals" pillar; full ROI by FY28	$2.7B premium price + ROIC compression; goodwill impairment risk

The Bull Case — Detail

Thesis: CPB is a fallen blue-chip staples paying 7.5%+ dividend while waiting for FY26 to mark the cyclical trough. PEAK savings of $375M cumulative by FY28 + Sovos synergy maturation + Rao's continued growth + tariff mitigation accelerating from 60% to 80% by FY27 + Snacks stabilization combine to lift FY27 adj EPS to ~$2.65 and FY28 to ~$3.05 (recovering to or above FY25's $2.97). Multiple compression from 9.5x → 11–12x as the recovery is recognized gives a fair value of $26–30 + $1.56 dividend over 18 months = ~32% total return.

Key bull-case data points:

• Rao's growing 5–10% annually; "approaching $1B" run-rate suggests meaningful M&B revenue growth
• PEAK delivered ~$145M cumulative by FY25; on-pace for $375M by FY28
• Tariff mitigation has time to mature (six-quarter learning curve)
• Free cash flow ~$600–700M supports dividend at 1.3–1.5x coverage in base case
• Stock at trough multiple = high asymmetric upside vs limited additional downside if dividend holds
• Dorrance family won't allow distressed dividend cut without a fight

The Bear Case — Detail

Thesis: CPB is structurally challenged. GLP-1 + private label expansion + retailer power are eroding the Snacks franchise (41% of revenue) permanently — not cyclically. Tariffs prove persistent through FY28, mitigation capped at 70% as supply chain reshoring increases the cost base. PEAK savings get absorbed by inflation + mix headwinds rather than flowing to bottom line. ROIC compresses below WACC. Net debt stays at 4.0x+ EBITDA through FY27, blocking buybacks. Dividend coverage breaks below 1.2x by FY27, forcing a 30–40% cut. Multiple stays at trough 9x on impaired EPS = $15–17 stock + cut dividend = -20–25% total return.

Key bear-case data points:

• 5 consecutive quarters of Snacks volume decline (FY25 Q1 through FY26 Q2)
• No CEO open-market buy despite 50% drawdown = soft management conviction
• Snyder's-Lance ROIC has never recovered after 8 years (precedent for ongoing Sovos drag)
• Tariff regime appears structural in current policy environment
• Net debt $6.5B at FY26 + slow deleveraging = no buyback through FY28
• Q2 FY26 cut was bigger than expected = trend not bottom
• Industry analyst consensus PT has fallen consistently for 6 quarters

What Would Change Each Side's Mind

Bull → Bear (bear-confirming events):

• Q3 FY26 (June 2026) print: another miss + Snacks volume <-5%
• FY26 dividend cut announcement (would prove bear thesis)
• Tariff escalation (additional categories)
• Goodwill impairment charge on Sovos
• Senior management departure
• Private label share gain >2 pts in core categories

Bear → Bull (bull-confirming events):

• Q3 FY26 print: Snacks volume stabilizes (-1 to flat); margin expansion +50 bps
• Tariff mitigation reported at 70%+ (vs 60% in March)
• Rao's reported at $1B+ annualized
• Snacks segment EBIT margin recovering toward 14%+
• Dividend reaffirmed in early FY27 with FCF >$700M
• Management open-market buying

Consensus Positioning

Source	Rating	PT	Notes
S&P Global consensus (20 analysts)	HOLD	$23.06	Implies modest upside; consistent with mid-base case [S3]
FY26 EPS consensus	$2.19	—	Mid of guidance
FY27 EPS consensus	$2.32	—	Implies modest recovery (+5.9%)
Buy-side sentiment	Slightly negative	—	Hedge-fund dividend-trap concern
Income-oriented funds	Adding	—	7.5% yield attractive

[S3]

Catalyst Calendar

Date	Event	Importance
June 2026	Q3 FY26 earnings	Highest — Snacks stabilization + tariff mit progress
Sept 2026	Q4 FY25 / FY26 + initial FY27 guidance	High — first FY27 view
Nov 2026	Annual Meeting	Moderate — governance
Dec 2026	Q1 FY27 earnings	High — first FY27 quarter
March 2027	Q2 FY27 earnings	High — first H2 with full PEAK ramp
Ongoing	Sovos integration milestones	Moderate — Rao's growth, synergy
Ongoing	Tariff policy developments	High — exogenous

Evidence and Sources

Expected Value Framing

Scenario	Probability	18-month TR	EV Contribution
Bull (Snacks stabilizes + tariff mit + multiple expansion)	30%	+35%	+10.5%
Base (modest recovery, dividend held)	45%	+10%	+4.5%
Bear (Snacks weaker + tariff persistent)	20%	-15%	-3.0%
Catastrophic (dividend cut + GLP-1 acceleration)	5%	-30%	-1.5%
Weighted Expected Value	100%	+10.5%	(over 18 months)

Read: Probability-weighted EV is modestly positive at the current price — a HOLD justification with bias to ADD on weakness below $20. The dividend yield is the income-buffer that converts a ~+10% TR thesis into a ~17–18% annualized total return on a holding period basis.

Reverse-DCF Cross-Check

For CPB to be fairly valued at $20.87:

• Implied 10-year growth: ~1.5% revenue, ~2% EBIT
• Implied terminal margin: ~13.5%
• Implied terminal WACC: 7%
• Implied terminal growth: 1.5%

The market is pricing modest decline + at-WACC ROIC + no margin expansion. The base/bull case requires only modest improvement vs this implied path to deliver returns. The bear case requires further deterioration.

Assumption Register Updates

(No new entries — confirms scenario probabilities used in valuation.)

Tables and Calculations

See Where They Disagree + Catalyst Calendar + Expected Value framing.

Open Questions and Data Gaps

1. Specific buy-side hedge fund positioning data (concentrated short interest) — not extracted
2. Options market implied volatility / skew (dividend cut probability) — not extracted
3. Credit spread on CPB bonds (debt market view) — not extracted
4. Insider conviction beyond Form 4 — only directional from public filings

Bull Case — 3 bullets

• PEAK savings ramp + Sovos integration + tariff mitigation maturing combine to lift FY27 adj EPS to ~$2.65 (+20% YoY) and FY28 to $3.05+, recovering above FY25's $2.97. Multiple compression from trough 9.5x to 11–12x on recovering EPS delivers a $26–28 fair value over 18 months [S1][S4].
• Dividend yield of 7.5%+ is rare in consumer staples and covered 1.4–1.5x by FY25/FY26E FCF; Dorrance family ownership + 40+ year payment record support the dividend through cycles. Receive 7.5%+ yield while waiting for thesis to resolve [S2][S6].
• Rao's continues to grow 5–10% annually and is now "approaching $1B" annualized — the premium meals platform is delivering on the M&A thesis even if Snyder's-Lance hasn't. M&B segment (59% of revenue, 17.8% margin) is the durable franchise [S1].

Bear Case — 3 bullets

• GLP-1 weight-loss drugs structurally impair the Snacks TAM by an estimated 5–15% over the next decade (~$200–600M annual revenue erosion). Combined with private label pressure and Snyder's-Lance share losses to Frito-Lay, the Snacks segment (41% of revenue) is in secular not cyclical decline [S7].
• Tariffs prove persistent through FY28, with mitigation capped at ~70% as supply chain reshoring lifts the cost base permanently. ROIC stays below WACC. PEAK savings get absorbed rather than flowing through to bottom line. EPS doesn't meaningfully recover [S3].
• Dividend coverage thins to 1.2x by FY27 in the bear case ($550M FCF / $465M dividend), forcing a 30–40% cut. Stock re-rates lower as the income thesis breaks; net debt at 4.0x+ blocks buybacks through FY28. Total return -20–25% [S2][S3].

Next-Step Dependencies

• Step 16 (Variant Perception) — tests where the market is mispricing the dividend / trough thesis
• Step 18 (Portfolio Fit) — sizing on the asymmetric return profile
• /complete-coverage Step 15 (Scenarios) — full bull/base/bear NPV math
• Public /stocks/[ticker] page — Bull/Bear 3-bullets render directly from this section

Source Index

Tag	Document	Path	Notes
[S1]	Q4 FY25 release	sec_filings/10K_FY2025_summary.md	FY25 results + Sovos progress + PEAK
[S2]	XBRL + 10-K	xbrl/xbrl_summary.md	FCF, dividend, leverage
[S3]	Q2 FY26 + consensus	other/consensus.md	Guidance cut + analyst views
[S4]	Investor Day Sept 2024	presentations/investor_presentation_2024.md	PEAK + capital allocation framework
[S5]	Beekhuizen biography + comp	proxy/governance_and_compensation.md	Management
[S6]	Form 4 inventory	proxy/insider_transactions.md	Insider activity / Dorrance
[S7]	Industry research + GLP-1	industry/market_overview.md + competitive_landscape.md	Structural risks